Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
AstraZeneca to offer up to 80% off US drug prices
AstraZeneca joins Trump’s drug pricing plan, pledging $50bn US investment and discounts of up to 80% to cut prescription medicine costs.
Read more
Could gene therapy transform heart failure treatment?
A gene therapy for heart failure with preserved ejection fraction (HFpEF) has shown promising early results.
Sanofi's chlamydia vaccine fast-tracked by FDA
This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.
New study shines light on dementia in the workplace
A new study is challenging the belief that dementia is incompatible with modern work environments, with AI helping employees stay in work.
Pharma’s innovation ROI: Gains made, challenges ahead
The biopharmaceutical industry’s return on investment in innovation is increasing, but R&D costs are rising, according to a new Deloitte report.
VPAG hikes put UK life sciences at risk, warns pharma
The industry already contributes more than £17.6 billion directly to the UK economy, but it believes that growth has stagnated because of VPAG.
Pfizer completes exit from Haleon
Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.
AstraZeneca buys EsoBiotec in $1bn cell therapy deal
AstraZeneca has announced a $1bn agreement to acquire EsoBiotec, a Belgian biotech firm pioneering in vivo cell therapies.
Daily pill for endometriosis to be offered by NHS
The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.
Loading posts...
« Previous
1
…
10
11
12
13
14
…
36
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View